Lobe Sciences Ltd.
LOBEF
$0.04
$0.000.00%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.75% | 31.59% | -123.53% | -10.85% | -39.90% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -263.46% | -83.65% | 68.11% | 145.93% | 341.03% |
| Change in Net Operating Assets | 234.07% | 307.05% | 191.07% | -66.72% | -33.98% |
| Cash from Operations | -134.69% | -2,694.23% | -22.85% | -1,001.29% | -154.61% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -3,793.58% | 2,364.48% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -97.51% | 2,288.46% | -- | -- |
| Foreign Exchange rate Adjustments | -84.38% | -991.30% | 206.35% | -478.95% | 2,700.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 163.84% | -1,113.28% | 31,288.89% | 97.09% | -124.93% |